고욤나무 잎으로부터 활성유도 분획법에 의한 α-Glucosidase 저해물질 분리 및 확인

To establish the anti-diabetic(α-glucosidase inhibitory) activity of D. lotus leaf extract, isolate and identify the constituents responsible for the activity. The methanolic extract of leaves was partitioned between water, n-butanol and ethyl acetate. Bio-assay guided fractionation, based on inhibi...

Full description

Saved in:
Bibliographic Details
Published in생약학회지 Vol. 46; no. 2; pp. 105 - 108
Main Authors 곽설화(Seol Hwa Kwak), 유강열(Kang Yeol Yu), 장선일(Seon Il Jang), 김선영(Seon Young Kim), 정승일(Seung Il Jeong), 김상준(Sang Jun Kim), 김지애(Ji Ae Kim), 김다혜(Da Hye Kim)
Format Journal Article
LanguageKorean
Published 한국생약학회 2015
Subjects
Online AccessGet full text
ISSN0253-3073
2288-9299

Cover

More Information
Summary:To establish the anti-diabetic(α-glucosidase inhibitory) activity of D. lotus leaf extract, isolate and identify the constituents responsible for the activity. The methanolic extract of leaves was partitioned between water, n-butanol and ethyl acetate. Bio-assay guided fractionation, based on inhibition of ;${\alpha}$-glucosidase, allowed isolation and identification of the active components. Liquid chromatography/mass spectrometry(LC/MS), 1 H-NMR and 13 C-NMR spectra analyses demonstrated that the active compound was myricetin-3-O-;${\alpha}$-L-rhamnoside(1). Compound 1 demonstrated a strong inhibition on the α-glucosidase, in vitro and ;${\alpha}$-glucosidase inhibitory value was calculated as 98.08%, when that of a reference drug, acarbose was estimated as 83.03%. The present study indicates compound 1 could be considered as an ;${\alpha}$-glucosidase inhibitor and developed as an important antidiabetes agent for type II diabetes therapy.
Bibliography:KISTI1.1003/JNL.JAKO201525850303395
ISSN:0253-3073
2288-9299